California Patent of the Month – June 2024
In the realm of medical advancements, Collidion, Inc. has emerged with a groundbreaking invention poised to revolutionize healthcare disinfection protocols. At the heart of their newly patented innovation lies a meticulously formulated composition designed to combat the pervasive challenge of pathogen transmission through medical devices, particularly critical and semi-critical items like endoscopes and catheters.
The composition combines precise ratios of polyhexamethylene biguanide and isopropanol, supplemented by compatible carriers. This synergy not only enhances efficacy but also addresses the critical need for gentler disinfection methods suitable for heat-sensitive devices. Traditional sterilization techniques often necessitate high temperatures and pressures, which can compromise device integrity and shorten their lifespan. In contrast, Collidion’s invention offers a balanced solution that effectively cleans, disinfects, and potentially sterilizes without compromising device materials.
This innovation arrives at a pivotal moment, given the escalating incidence of healthcare-associated infections linked to inadequately disinfected medical devices. The composition’s application extends beyond mere disinfection—it signifies a paradigm shift towards safer healthcare practices, mitigating risks associated with cross-contamination and microbial transmission.
Endoscopes, notorious for their susceptibility to microbial contamination due to exposure in challenging bodily cavities, stand to benefit significantly from this advancement. The composition’s ability to maintain device integrity while ensuring superior disinfection could potentially reduce the occurrence of infectious outbreaks traced back to medical equipment.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
